First Diagnostic Agent Approved to Image Tau Pathology in Patients Being Evaluated for Alzheimer Disease
Tauvid is indicated for use with positron emission tomography (PET) imaging of the brain.
Tauvid is indicated for use with positron emission tomography (PET) imaging of the brain.
Plasma phosphorylated tau181 (P-tau181) may aid in the diagnosis of Alzheimer disease (AD), a study in Natural Medicine suggests.
More than half of individuals with Down syndrome aged 55 years or older have dementia claims and 32.7% have Alzheimer disease (AD) claims.
Low and high hemoglobin levels were associated with increased risk for dementia, white matter hyperintensity volume, and structural connectivity.
Pupillary dilation during cognitive tasks is associated with Alzheimer disease polygenic risk score.
Most cerebrovascular risk factors are linked to a higher risk for subsequent diagnosis of Parkinson disease.
These products may prevent patients from seeking appropriate treatment.
Researchers identified current gaps in aging and diversity research and identified future directions that research should take.
There may be possible benefits for long-term hormone therapy, but the results are not definitive.
Witnessing a loved one succumb to Alzheimers disease (AD) is one of the most difficult experiences a person has to deal with. Signs of the disease appear slowly at first. The affected individual may forget a word or misplace an object, which is something that happens to everyone from time to time. But then it gets more serious.